Related Experiment Video

Updated: May 24, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Hypothyroidism: age-related influence on cardiovascular nitric oxide system in rats

Lorena I Sarati1, Carla R Martinez, Nicolás Artés

  • 1Department of Physiology, School of Pharmacy and Biochemistry, Universidad de Buenos Aires, Buenos Aires, Argentina, IQUIMEFA-CONICET. ivonnesarati@conicet.gov.ar

Metabolism: Clinical and Experimental
|March 20, 2012
PubMed

Insights

Hypothyroidism impacts cardiovascular function, altering nitric oxide (NO) production and enhancing age-related heart changes. These effects on NO pathways and cardiovascular tissues vary with age.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Molecular Biology

Background:

  • Cardiovascular manifestations are common in hypothyroidism.
  • Nitric oxide (NO) plays a crucial role in cardiovascular regulation.
  • Age-related changes can influence cardiovascular function and NO pathways.

Purpose of the Study:

  • To investigate the role of NO production in cardiovascular changes associated with hypothyroidism.
  • To determine if these NO changes are influenced by age.
  • To examine the effects of hypothyroidism on cardiac and vascular function in different age groups.

Main Methods:

  • Hypothyroidism was induced in young (2-month-old) and adult (18-month-old) Sprague-Dawley rats using methimazole.
  • Cardiovascular function was assessed via echocardiography.
  • Measurements included blood pressure, heart rate, nitric oxide synthase (NOS) activity, and NOS/caveolin protein levels.

Main Results:

  • Hypothyroidism exacerbated age-related cardiac dysfunction.
  • Atrial NOS activity decreased in both young and adult hypothyroid rats.
  • Ventricle and aorta NOS activity increased in hypothyroid rats, with age-dependent alterations in NOS isoforms and caveolin expression.

Conclusions:

  • Thyroid hormones modulate cardiovascular NO production and caveolin levels in a tissue-specific manner, independent of age.
  • Hypothyroidism differentially affects aging-induced changes in the myocardium and aorta.
  • Reduced thyroid hormones may amplify age-related cardiac decline, with NO pathway alterations contributing to cardiovascular manifestations.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...